SLC2A5 and acute myeloid leukemia: To overcome such glucose depletion, AML cells may utilise fructose through the upregulation of the fructose transporter GLUT5, and, as such, treatment with the fructose analogue 2,5-anhydro-d-mannitol (2,5-AM) prevents cellular proliferation in AML [229].